Hair fall, or hair loss, is a common dermatological problem that has several underlying causes. In some cases, it may be ...

Q32 Bio, of Waltham, Mass., announced on April 30, 2025 that its human anti-IL-7Rα antibody, bempikibart (ADX-914), has been given fast track designation by FDA for the treatment of alopecia areata ...

Although the origin of alopecia areata, a “common chronic tissue-specific autoimmune disease,” is not renal, it is associated with a higher risk of developing CKD.

While this topical treatment has been shown to be effective for many people, it doesn’t work for everyone. And if you have serious hair loss, it probably won’t be very effective.

Mild alopecia areata ranges from 0% to 20%, moderate is from 21% to 49%, and severe is from 50% to 100%. A SALT score of 20 or less is recognized as a meaningful improvement for people with ...

Ways to Treat Alopecia Areata While there’s not much evidence supporting things to avoid when you have alopecia areata, there are ways to treat your condition. One recommended treatment for ...

Alopecia Areata Clinical Trials Paving the Way for Treatment Innovations Interest in alopecia areata has skyrocketed since the 94th Academy Awards ceremony, during which stand-up comedian Chris ...

Researchers compared treatment with onion juice to placebo (a substance with no therapeutic effect, given to people in a clinical trial control group) in participants with alopecia. After eight weeks, ...

A study from China found topicals and minoxidil solutions were the most effective, safe, and cost-effective forms of therapy for pediatric patients with alopecia areata (AA) while tofacitinib and ...

Alopecia areata is a non-scarring type of hair loss, and the hair follicles remain alive, which means the hair can regrow. Doctors may treat alopecia areata with an injection into the scalp every ...

According to Yale Medicine, alopecia areata is an autoimmune disease that affects almost two out of 100 people and recurs even after many mainstream treatments like using steroids.